Table 2.

The effects of puerarin on prefrontal cortex monoamine neurotransmitter levels in CUS rats.

Groups	5-HT	5-HIAA	NE	AD	HVA	DA	DOPAC
CUS (−)	194.5 ± 26.15	147.0 ± 23.24	118.0 ± 12.12	153.7 ± 20.57	47.83 ± 4.408	43.50 ± 3.888	51.50 ± 6.893
CUS (+)	85.83 ± 9.325##	83.50 ± 9.929#	115.2 ± 14.47	165.0 ± 22.84	49.00 ± 6.787	51.83 ± 4.840	59.33 ± 5.200
Ser 15 mg/kg, i.g	163.0 ± 29.14*	151.8 ± 22.81*	130.5 ± 17.84	162.0 ± 22.89	60.50 ± 9.280	56.33 ± 6.238	52.67 ± 8.531
puerarin 30 mg/kg, i.g	126.5 ± 18.30	113.5 ± 11.30	138.2 ± 16.45	186.3 ± 21.84	60.33 ± 7.953	54.67 ± 7.491	53.33 ± 5.512
puerarin 60 mg/kg, i.g	181.5 ± 21.61*	149.2 ± 10.94*	134.5 ± 24.30	180.0 ± 25.41	50.50 ± 8.782	55.17 ± 6.740	52.83 ± 4.722
puerarin 120 mg/kg, i.g	164.5 ± 16.87*	158.5 ± 18.88*	125.2 ± 10.76	148.7 ± 14.97	59.33 ± 7.297	51.83 ± 5.902	55.17 ± 4.578

^# p < 0.05, ^## p < 0.01 vs. vehicle-treated CUS (−) group; *p < 0.05 vs. vehicle-treated CUS (+) group (n = 6).